Does gender influence P300 latency and mini mental state examination score in type 2 diabetes mellitus patients?

2021 ◽  
pp. 1
Author(s):  
Bhanu R ◽  
Vinutha S ◽  
Pramodh V
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Mental State ◽  
Mini Mental State Examination ◽  
P300 Latency ◽  
Examination Score ◽  
Gender Influence ◽  
State Examination

scholarly journals Effect of Astaxanthin supplementation on cognitive function and depression in Patients with Type 2 Diabetes Mellitus

2020 ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cognitive Function ◽  
Mental State ◽  
Mini Mental State Examination ◽  
Mmse Score ◽  
Beneficial Effects ◽  
State Examination

Background: The oral administration of Astaxanthin may decrease depression symptoms and improved cognitive function through its beneficial effects on inflammation, and oxidative stress. Objective: This study was designed to assess whether Astaxanthin supplementation can reduce symptoms of depression and increase MMSE score in patients with Type 2 Diabetes Mellitus. Methods: This randomized, double-blind, placebo-controlled clinical trial was performed in 44 patients between 30 and 60 y of age with a diagnosis of type 2 diabetes. Patients were randomly assigned to receive either a single capsule of 8 mg of Astaxanthin /day (n = 22) or placebo (n = 22) for 8 wk. The primary [Beck Depression Inventory (BDI), which examines depressive symptoms] and secondary (Mini-Mental State Examination (MSSE) score, which evaluates cognitive function) outcomes were assessed. Results: After 8 week of intervention, Mini-Mental State Examination baseline score was significantly improved only in the group treated with Astaxanthin, during study (p < 0.01). But no significant reduction in the Beck Depression Inventory (BDI) was observed in both group. Conclusion: Overall, Astaxanthin supplementation of patients with diabetes for 8 weeks had beneficial effects on the MMSE score. Key words: Astaxanthin, Cognitive function Depression

scholarly journals Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study

2005 ◽  
Vol 43 (10) ◽  
Author(s):  
Michael A. Robbins ◽  
Merrill F. Elias ◽  
Marc M. Budge ◽  
Suzanne L. Brennan ◽  
Penelope K. Elias
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Type 2 Diabetes Mellitus ◽  
Cognitive Performance ◽  
Disease Incidence ◽  
Statistical Adjustment ◽  
State Examination ◽  
Cardiovascular Disease Incidence

AbstractType 2 diabetes mellitus and higher total plasma homocysteine concentrations are each associated with an increased incidence of cardiovascular disease and with diminished cognitive performance. Relations between homocysteine concentrations and cardiovascular disease incidence are stronger in the presence of type 2 diabetes mellitus. Therefore, we hypothesized that relations between homocysteine concentrations and cognitive performance would be stronger in the presence of type 2 diabetes. We related homocysteine concentrations and cognitive performance on the Mini-Mental State Examination in 817 dementia- and stroke-free participants of the Maine-Syracuse Study, 90 of whom were classified with type 2 diabetes mellitus. Regardless of statistical adjustment for age, sex, gender, vitamin co-factors (folate, vitamin B

Mental state, psychoemotional status, quality of life and treatment compliance in patients with Type 2 diabetes mellitus

2019 ◽  
Vol 8 (2) ◽  
pp. 113-120 ◽  
Author(s):  
Alina Y Babenko ◽  
Anna A Mosikian ◽  
Denis L Lebedev ◽  
Elizaveta A Khrabrova ◽  
Evgeniy V Shlyakhto
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Mental State ◽  
Treatment Compliance

scholarly journals The relationship between fatigue severity and mild cognitive impairment in Saudi patients with type 2 diabetes mellitus

2022 ◽  
Author(s):  
Fouad Fathy Bahgat ◽  
Ibrahim Majed Fetyani ◽  
Ali Hamad Alnasser ◽  
Abdulmohsen Mohammed Alkhalaf ◽  
Mohammed Omar Baqais ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Saudi Arabia ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Mental State ◽  
Cognitive Assessment ◽  
Fatigue Severity

Type 2 Diabetes Mellitus (T2DM) is a major health issue in Saudi Arabia, with a prevalence of 23.7% in 2015. Several factors contribute to the occurrence of Mild Cognitive Impairment (MCI) and its progression to Alzheimer's disease in patients with T2DM. This study assesses MCI and fatigue severity and their relationship in patients with T2DM. Out of the 160 Saudi adults interviewed at the King Khalid University Hospital in Riyadh from October 2019 till March 2020, 80 were known cases of T2DM while the rest were non-diabetic individuals. The Montreal Cognitive Assessment (MoCA) test, Mini Mental State Exam (MMSE) and Fatigue Severity Score (FSS) were used to evaluate MCI and fatigue severity, respectively. According to the MoCA scale, 68.7% diabetic individuals as against 42.5% from the non-diabetic group had MCI. While the FSS showed that 40% of the diabetic group vs 26.3% of the non-diabetic were fatigued. In conclusion, patients with T2DM are at a higher risk of developing MCI. Keywords: Type 2 diabetes mellitus, Mild cognitive impairment, Fatigue, Mini mental state exam, Montreal Cognitive Assessment, Saudi Arabia.

Sign in / Sign up

Export Citation Format

Share Document